Abstract:To investigate potential biomarkers and biological processes associated with diabetic retinopathy (DR) using transcriptomic and proteomic data. The OmicsPred PheWAS application was interrogated to identify genes and proteins associated with DR and diabetes mellitus (DM) at a false discovery rate (FDR)-adjusted p-value of <0.05 and also <0.005. Gene Ontology PANTHER analysis and STRING database analysis were conducted to explore the biological processes and protein interactions related to the identified biomarkers. The interrogation identified 49 genes and 22 proteins associated with DR and/or DM; these were divided into those uniquely associated with diabetic retinopathy, uniquely associated with diabetes mellitus, and the ones seen in both conditions. The Gene Ontology PANTHER and STRING database analyses highlighted associations of several genes and proteins associated with diabetic retinopathy with adaptive immune response, valyl-TRNA aminoacylation, complement activation, and immune system processes. Our analyses highlight potential transcriptomic and proteomic biomarkers for DR and emphasize the association of known aspects of immune response, the complement system, advanced glycosylation end-product formation, and specific receptor and mitochondrial function with DR pathophysiology. These findings may suggest pathways for future research into novel diagnostic and therapeutic strategies for DR.

What problem does this paper attempt to address?

The paper aims to explore the relevant genes and proteins of diabetic retinopathy (DR) as potential biomarkers for retinal disease inflammation models. Specifically, the study identifies genes and proteins associated with diabetic retinopathy and diabetes through transcriptomics and proteomics data, and analyzes the biological processes and protein interactions involved with these biomarkers. The main objectives of the study include: 1. **Identification of Biomarkers**: Using the OmicsPred PheWAS application tool, 49 genes and 22 proteins significantly associated with diabetic retinopathy and diabetes were identified. 2. **Exploration of Biological Processes**: Through Gene Ontology PANTHER analysis and STRING database analysis, the roles of these genes and proteins in adaptive immune response, valine-tRNA aminoacylation, complement activation, and immune system processes were explored. 3. **Revealing Pathological Mechanisms**: The study results emphasize the known associations between immune response, complement system, advanced glycation end-product formation, specific receptors, and mitochondrial function with the pathophysiology of diabetic retinopathy. 4. **Guiding Future Research**: These findings may provide pathways for developing new diagnostic and therapeutic strategies. In summary, the study aims to deeply understand the molecular mechanisms of diabetic retinopathy through multi-omics approaches and provide new insights for prevention and treatment.

Exploring the Associated Genetic Causes of Diabetic Retinopathy as a Model of Inflammation in Retinal Diseases